ConductScience.org, home

Paper41044643

LCP1 upregulation via EGFR signaling promotes oral cancer progression through the JAK2/STAT3/IL-1β axis.

Liu CR and 7 others. Cancer Cell Int, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. LCP1 upregulation via EGFR signaling promotes oral cancer progression through the JAK2/STAT3/IL-1β axis. Papers, record 41044643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41044643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
LCP1 upregulation via EGFR signaling promotes oral cancer progression through the JAK2/STAT3/IL-1β axis.
PubMed
Journal
Cancer Cell Int
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-10-07
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu CRChiao-Rou
2Yang CYChia-Yu
3Chang KPKai-Ping
4Chan XYXiu-Ya
5Hung CMChu-Mi
6Lai KMKuan-Ming
7Liu HPHao-Ping
8Wu CCChih-Ching

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
111-2314-B-182A-078-MY3National Science and Technology Council, TaiwanPubMed
113-2313-B-005-014National Science and Technology Council, TaiwanPubMed
112-2320-B-182-044National Science and Technology Council, TaiwanPubMed
CMRPG3J1253Chang Gung Memorial Hospital, TaiwanPubMed
BMRPC77Chang Gung Memorial Hospital, TaiwanPubMed
NCHU-CCH11306National Chung Hsing University/Changhua Christian Hospital Joint Research ProgramPubMed
NCHU-CCH11306National Chung Hsing University/Changhua Christian Hospital Joint Research ProgramPubMed
NSTC 114-2320-B-182-025National Science and Technology CouncilPubMed

Source PubMed

Download CSV of grants

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123362108Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma.J Pathol2013https://conductscience.org/library/papers/23362108PubMed
233739025An integrated approach for identification of a panel of candidate genes arbitrated for invasion and metastasis in oral squamous cell carcinoma.Sci Rep2021https://conductscience.org/library/papers/33739025PubMed
316636079Phosphorylation on Ser5 increases the F-actin-binding activity of L-plastin and promotes its targeting to sites of actin assembly in cells.J Cell Sci2006https://conductscience.org/library/papers/16636079PubMed
418645125Biological markers and prognosis in recurrent oral cancer after salvage surgery.Arch Otolaryngol Head Neck Surg2008https://conductscience.org/library/papers/18645125PubMed
510629546Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma.J Pathol1999https://conductscience.org/library/papers/10629546PubMed
632610557Cotargeting CHK1 and PI3K Synergistically Suppresses Tumor Growth of Oral Cavity Squamous Cell Carcinoma in Patient-Derived Xenografts.Cancers (Basel)2020https://conductscience.org/library/papers/32610557PubMed
737501404Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer.Mol Oncol2023https://conductscience.org/library/papers/37501404PubMed
836209263Tumor microenvironment and immunotherapy of oral cancer.Eur J Med Res2022https://conductscience.org/library/papers/36209263PubMed
939780248Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy.Mol Cancer2025https://conductscience.org/library/papers/39780248PubMed
1026919428NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria.Cell2016https://conductscience.org/library/papers/26919428PubMed
1124555657
Stable SET knockdown in head and neck squamous cell carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro, as well as necrosis, cisplatin sensitivity and lymph node metastasis in xenograft tumor models.
Mol Cancer2014https://conductscience.org/library/papers/24555657PubMed
1238560690Interplay of p62-mTORC1 and EGFR signaling promotes cisplatin resistance in oral cancer.Heliyon2024https://conductscience.org/library/papers/38560690PubMed
1331253657Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches.Mol Cell Proteomics2019https://conductscience.org/library/papers/31253657PubMed
1435048046IL-1/IL-1R Signaling in Head and Neck Cancer.Front Oral Health2021https://conductscience.org/library/papers/35048046PubMed
1520169155Quantitative kinetic study of the actin-bundling protein L-plastin and of its impact on actin turn-over.PLoS One2010https://conductscience.org/library/papers/20169155PubMed
1630409303Label-free tissue proteomics can classify oral squamous cell carcinoma from healthy tissue in a stage-specific manner.Oral Oncol2018https://conductscience.org/library/papers/30409303PubMed
1722825581Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.Clin Cancer Res2012https://conductscience.org/library/papers/22825581PubMed
1825204733IL-1β promotes malignant transformation and tumor aggressiveness in oral cancer.J Cell Physiol2015https://conductscience.org/library/papers/25204733PubMed
1919924637Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma.Histol Histopathol2010https://conductscience.org/library/papers/19924637PubMed
2037079976Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer.Arch Oral Biol2023https://conductscience.org/library/papers/37079976PubMed

See all 66 referencesDownload CSV of references

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41044643

GET https://conductscience.org/api/papers/v1/41044643/references?page=2